The overall objective of the guideline is to provide up-to-date, evidence-based recommendations for the management of lichen sclerosus (LS) in adults (18+ years), children (0-12 years) and young people (13-17 years). The document aims to.
offer an appraisal of all relevant literature up to July 2017, focusing on any key developments.
address important, practical clinical questions relating to the primary guideline objective.
provide guideline recommendations and if appropriate research recommendations.
The guideline is presented as a detailed review with highlighted recommendations for practical use in primary care and in secondary care clinics, in addition to an updated Patient Information Leaflet (PIL; available on the BAD website, http://ift.tt/1tltLhk).
This article is protected by copyright. All rights reserved.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2CMUfP7
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου